They have form for sure but this time they need a deal and this time they are a P3 company.
They just can't raise enough with a CR IMO.
I think the SP in the next few weeks will give us a lot of clues as to where this is going. Always potential for a pump then a dump that's happened before too
- Forums
- ASX - By Stock
- PAR
- Ann: Notice of General Meeting/Proxy Form
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.84%
!
29.5¢

Ann: Notice of General Meeting/Proxy Form, page-79
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $114.8M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 29.0¢ | $67.50K | 220.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 44652 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 0.290 |
7 | 110688 | 0.285 |
20 | 268416 | 0.280 |
7 | 73263 | 0.275 |
6 | 106424 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 44652 | 7 |
0.305 | 2746 | 1 |
0.310 | 57505 | 3 |
0.315 | 59233 | 3 |
0.320 | 108906 | 8 |
Last trade - 13.04pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online